'Speculative Bearish' Options Positioning Continues in Valeant Pharma (VRX) -Susquehanna

Susquehanna options strategist Alison Edwards notes speculative bearish positioning in Valeant Pharma (NYSE: VRX), as opening investors bought a total of 35,000 Nov 11 Puts for $0.40, followed by 12,000 Jan 12.5 Puts bought for $1.12.

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 3.9 calls to 1 put with a focus on 1600 contracts of October 2 weekly 24 calls into quarter results
• Zscaler (ZS) call put ratio 1.6 calls to 1 put with a focus on October 190 puts
• Hyperliquid Strategies (PURR) September 25 weekly 15 and October 14 calls active, share price down 8.2%